ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor

Christine Song, Ayse Tuba Kendi, Ji Yeon Shim, Dawa Jung, Pil Soo Kang, Val J. Lowe, Seung Baek Lee

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences